介入栓塞化疗联合调强放疗对晚期宫颈癌近期疗效临床研究  

Therapeutic effects of super-selective bilateral uterine arterial chemoembolization therapy and radiotherapy for advanced uterine cervical cancer

作　　者：余雷[1] 陈燕浩[1] 刘智勇[1] 易小宇[1] 覃汉德[1] 

机构地区：[1]广西壮族自治区人民医院普通介入科,南宁530021

出　　处：《中国临床新医学》2015年第8期718-719,共2页CHINESE JOURNAL OF NEW CLINICAL MEDICINE

基　　金：广西医疗卫生重点科研课题(编号:重2010045)

摘　　要：目的探讨介入栓塞化疗联合调强放疗对晚期宫颈癌的近期疗效。方法入组41例宫颈癌患者,肿瘤分期Ⅱ期患者11例,Ⅲ期患者16例,Ⅳ期患者14例,均进行介入栓塞化疗及调强放疗。观察治疗后患者的近期有效率、获益率及治疗前后肿瘤直径变化情况。结果各肿瘤分期患者总有效率为46.3%,获益率为85.4%,各期肿瘤大小治疗后较治疗前均有显著缩小(P<0.05)。结论介入栓塞化疗联合调强放疗是晚期宫颈癌有效的治疗方法,近期疗效显著。Objective To explore the therapeutic effects of super-selective bilateral uterine arterial chemo-embolization therapy and radiotherapy for advanced uterine cervical cancer .Methods 41 patients with advanced u-terine cervical cancer received super-selective bilateral uterine arterial chemoembolization therapy .The effective rate , clinical beneficial rate and diameter changes of tumor before and after the treatment were observed .Results The ef-fective rate was 46.3%and the clinical beneficial rate was 85.4%.The tumor diameter after the treatment was smal-ler than that before the treatment .Conclusion Super-selective bilateral uterine arterial chemoembolization therapy is an effective treatment for the advanced uterine cervical cancer with significant short -term effects.

关 键 词：晚期宫颈癌 介入栓塞化疗 调强放疗 

分 类 号：R737.33[医药卫生—肿瘤]